颜色增强

◀返回

颜色增强喵，被定义为外部环境中颜色亮度和鲜艳程度的强化。在这种体验下，红色可能会显得“更红”，绿色也可能显得“更绿”，而且所有的颜色都会比平时清醒的时候看起来更清晰、更复杂，视觉冲击力也更强呢。[1][2][3][4][5][6][7] 在更高强度的状态下，这种效应有时会导致看到一些被认为超现实或看似不可能存在的颜色哦。[3][4]

颜色增强通常伴随着其他同时发生的效应，比如视觉锐度增强和模式识别增强呢。[1][2] 这种情况最常见于受到轻微剂量的迷幻剂类物质影响时，比如LSD、赛洛西宾和麦斯卡林喵。不过，在某些兴奋剂和解离剂的影响下，也可能在较小程度上发生，比如MDMA、氯胺酮 [8]或3-MeO-PCP哦。

图像示例

图片	描述
	显示差异，作者：Chelsea Morgan
	天堂岛，作者：Subsentience
	瑞士库尔市，作者：Naps284
	森林，作者：Chelsea Morgan
	日本庭园，作者：匿名
	变色龙，作者：匿名
	玫瑰，作者：Chelsea Morgan

体验报告

描述了这种效应的轶事报告可以在我们的主观效应索引中找到，包括：

Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus_-_A_pleasant_low-dose_evening_with_Nexus)
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)/_100ug_1P-LSD(sublingual)-_My_first_time_tripping_alone(2_days_in_a_row))
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis_%2B_2-FMA_(20mg)%2B_4-AcO-DMT(10mg)_-_Emotional_catharsis)
Experience:1000 Morning Glory seeds - Rediscovering the Self
Experience:100ug 1P-LSD - A Fear and loathing into Bliss
Experience:1050 µg 1cP-LSD - The matrix
Experience:120mg - Garden of The Gods
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
Experience:1mg 25c-NBOMe - Experiment in my room
Experience:2 tabs DOB - My DOB Nightmare
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity))
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
Experience:250mg DXM - DXM Itch and Trip Report
Experience:25mg 2C-B - Hard raving at home
Experience:25mg 3-MeO-PCP - Enhanced film experience
Experience:25mg Deschloroketamine - My first time orally dosing DCK
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea_-_Asymmetrical_Terror_and_the_Geometric_Sea)
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
Experience:3-MeO-PCP - Extreme psychosis
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
Experience:300µg AL-LAD - Don't worry, because you're everyone!
Experience:300µg LSD - Togetherness and the Silent Dusk
Experience:337mg DMT fumarate - A Day With DMT
Experience:3g mimosa / 3g syrian rue - Connecting with my body
Experience:4-AcO-DMT + 200mg Pill
Experience:4-HO-MiPT / A care free psychedelic getaway
Experience:4.5g - The Grand Introduction to Beauty and Fear
Experience:40mg - Brothermind and the Forest's Hand
Experience:4x 200ug tabs - You do not need to understand
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
Experience:800 seeds LSA - My First Trip Ever
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
Experience:BK-2C-B - Various experiences
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams))
Experience:Pregabalin (450mg, oral) + Methylphenidate (20mg, oral) - Gaba Flipping_%2B_Methylphenidate_(20mg,oral)-_Gaba_Flipping)
Experience:Psilocybin Mushroom (0.16 g, Oral) - Dosage Independent Intensity_-_Dosage_Independent_Intensity)
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death_-_Overdosing_and_Terifying_Ego_Death)
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
Experience:~150mg MDA(oral) - a case of mistaken identity_-_a_case_of_mistaken_identity)

另见

外部链接

参考文献

↑ Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11.
↑ Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6.
↑ Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451.
↑ Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts". Schizophrenia Bulletin. 3* (4): 560–586.
↑ Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42.
↑ Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884.
↑ Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67.
↑ Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28.